Deciphering leukemic B-cell chronic lymphoproliferative disorders

Leukemia and Lymphoma

Volumn 47, Issue 10, 2006, Pages 2088-2095

  Ugo, Valérie ^a   Leporrier, Nathalie ^b   Salaun, Véronique ^b   Letestu, Rémi ^c   Radford Weiss, Isabelle ^d   Ramond, Sylvie ^e   Nataf, Joelle ^e   Guesnu, Martine ^f   Picard, Françoise ^f   Brouzes, Chantal ^e   Perrot, Jean Yves ^e   Valensi, Françoise ^d   Levy, Vincent ^g   Ajchenbaum Cymbalista, Florence ^c   Troussard, Xavier ^b  

^a BREST UNIVERSITY HOSPITAL   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c AVICENNE HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e HÔTEL DIEU   (France)

^f CHU Cochin ^*  (France)

^g SAINT LOUIS HOSPITAL   (France)

Author keywords

Atypical chronic lymphocytic leukemia; B cell chronic lymphoproliferative disorders; B CLL; CD20; P27 kip1; Prognosis

Indexed keywords

CD20 ANTIGEN; CD5 ANTIGEN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN P27;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER PATIENT; CANCER SURVIVAL; CELL PROLIFERATION; CELL STRUCTURE; CHROMOSOME 11; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 17P; CHROMOSOME DELETION; CHROMOSOME DELETION 13; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 8; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FRANCE; GENETIC ANALYSIS; HEMATOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LYMPH NODE BIOPSY; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM;

AGED; ANTIGENS, CD20; ANTIGENS, CD5; CELL CYCLE; COHORT STUDIES; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 33750477310     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600727939     Document Type: Article

References (36)

1. Thieblemont, C and Nasser, V and Felman, P and Leroy, K and Gazzo, S and Callet-Bauchu, E and (2004) Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis Blood, 103, pp. 2727-2737.
2. Matutes, E and Owusu-Ankomah, K and Morilla, R and Garcia Marco, J and Houlihan, A and Que, T and (1994) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL Leukemia, 8, pp. 1640-1645.
3. Moreau, E and Matutes, E and A'Hern, R and Morilla, A and Morilla, R and Owusu-Ankomah, K and (1997) Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b) Am J Clin Pathol, 108, pp. 378-382.
4. Dohner, H and Stilgenbauer, S and Benner, A and Leupolt, E and Krober, A and Bullinger, L and (2000) Genomic aberrations and survival in chronic lymphocytic leukemia N Engl J Med, 343, pp. 1910-1916.
5. Gazzo, S and Baseggio, L and Coignet, L and Poncet, C and Morel, D and Coiffier, B and (2003) Cytogenetic and molecular delineation of a region of chromosome 3q commonly gained in marginal zone B-cell lymphoma Haematologica, 88, pp. 31-38.
6. Sanchez-Izquierdo, D and Buchonnet, G and Siebert, R and Gascoyne, R and Climent, J and Karran, L and (2003) Splenic marginal-zone lymphoma: A distinct clinical and pathological entity Lancet Oncol, 4, pp. 95-103.
7. Oscier, D and Owen, R and Johnson, S. (2005) Splenic marginal zone lymphoma Blood Rev, 19, pp. 39-51.
8. Jares, P and Fernandez, P and Campo, E and Nadal, A and Bosch, F and Aiza, G and (1994) PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma Blood, 84, pp. 2726-2732.
9. Criel, A and Michaux, L and de Wolf-Peeters, C. (1999) The concept of typical and atypical chronic lymphocytic leukaemia Leuk Lymphoma, 33, pp. 33-45.
10. Evans, W and Cheok, M and Yang, W and Sherr, C. (2003) Expression arrays illuminate a way forward for mantle cell lymphoma Cancer Cell, 3, pp. 100-102.
11. Polyak, K and Lee, M and Erdjument-Bromage, H and Koff, A and Roberts, J and Tempst, P and (1994) Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals Cell, 78, pp. 59-66.
12. Coats, S and Flanagan, W and Nourse, J and Roberts, J. (1996) Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle Science, 272, pp. 877-880.
13. Kudoh, S and Kumaravel, T and Kuramavel, B and Eguchi, M and Asaoku, H and Dohy, H and (1999) Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma Jpn J Cancer Res, 90, pp. 1262-1269.
14. Bennett, J and Catovsky, D and Daniel, M and Flandrin, G and Galton, D and Gralnick, H and (1989) Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group J Clin Pathol, 42, pp. 567-584.
15. Jaffe, E and Harris, N and Stein, H and Vardiman, J. (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press.
16. Mitelman, F. (1995) An International System for Human Cytogenetic Nomenclature. Basel: S. Karger.
17. Uchimaru, K and Taniguchi, T and Yoshikawa, M and Asano, S and Arnold, A and Fujita, T and (1997) Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma Blood, 89, pp. 965-974.
18. Vrhovac, R and Delmer, A and Tang, R and Marie, J and Zittoun, R and Ajchenbaum-Cymbalista, F. (1998) Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia Blood, 91, pp. 4694-4700.
19. Letestu, R and Ugo, V and Valensi, F and Radford-Weiss, I and Nataf, J and Levy, V and (2004) Prognostic impact of p27KIP1 expression in cyclin D1 positive lymphoproliferative disorders Leukemia, 18, pp. 953-961.
20. Au, W and Horsman, D and Ohno, H and Klasa, R and Gascoyne, R. (2002) Bcl-3/IgH translocation (14;19)(q32;q13) in non-Hodgkin's lymphomas Leuk Lymphoma, 43, pp. 813-816.
21. Montserrat, E. (1997) Chronic lymphoproliferative disorders Curr Opin Oncol, 9, pp. 34-41.
22. Stone, R. (1990) Prolymphocytic leukemia Hematol Oncol Clin North Am, 4, pp. 457-471.
23. Troussard, X and Valensi, F and Duchayne, E and Garand, R and Felman, P and Tulliez, M and (1996) Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hematologie Cellulaire (GFHC) Br J Haematol, 93, pp. 731-736.
24. Troussard, X and Maloisel, F and Flandrin, G. (1998) Hairy cell leukemia. What is new 40 years after the first description? Hematol Cell Ther, 40, pp. 139-148.
25. Matutes, E and Polliack, A. (2000) Morphological and immunophenotypic features of chronic lymphocytic leukemia Rev Clin Exp Hematol, 4, pp. 22-47.
26. Berland, R and Wortis, H. (2002) Origins and functions of B-1 cells with notes on the role of CD5 Annu Rev Immunol, 20, pp. 253-300.
27. Chiorazzi, N and Ferrarini, M. (2003) B cell chronic lymphocytic leukemia: Lessons learned from studies of the B cell antigen receptor Annu Rev Immunol, 21, pp. 841-894.
28. Orchard, J and Garand, R and Davis, Z and Babbage, G and Sahota, S and Matutes, E and (2003) A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease Blood, 101, pp. 4975-4981.
29. Peghini, P and Fehr, J. (2002) Analysis of cyclin D1 expression by quantitative real-time reverse transcription-polymerase chain reaction in the diagnosis of mantle cell lymphoma Am J Clin Pathol, 117, pp. 237-245.
30. Nowakowski, G and Dewald, G and Hoyer, J and Paternoster, S and Stockero, K and Fink, S and (2005) Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia Br J Haematol, 130, pp. 36-42.
31. Frater, J and McCarron, K and Hammel, J and Shapiro, J and Miller, M and Tubbs, R and (2001) Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically Am J Clin Pathol, 116, pp. 655-664.
32. Delgado, J and Matutes, E and Morilla, A and Morilla, R and Owusu-Ankomah, K and Rafiq-Mohammed, F and (2003) Diagnostic significance of CD20 and FMC7 expression in B-cell disorders Am J Clin Pathol, 120, pp. 754-759.
33. Bigoni, R and Cuneo, A and Roberti, M and Bardi, A and Rigolin, G and Piva, N and (1997) Chromosome aberrations in atypical chronic lymphocytic leukemia: A cytogenetic and interphase cytogenetic study Leukemia, 11, pp. 1933-1940.
34. Criel, A and Verhoef, G and Vlietinck, R and Mecucci, C and Billiet, J and Michaux, L and (1997) Further characterization of morphologically defined typical and atypical CLL: A clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases Br J Haematol, 97, pp. 383-391.
35. Matutes, E and Oscier, D and Garcia-Marco, J and Ellis, J and Copplestone, A and Gillingham, R and (1996) Trisomy 12 defines a group of CLL with atypical morphology: Correlation between cytogenetic, clinical and laboratory features in 544 patients Br J Haematol, 92, pp. 382-388.
36. Schwaenen, C and Nessling, M and Wessendorf, S and Salvi, T and Wrobel, G and Radlwimmer, B and (2004) Automated array-based genomic profiling in chronic lymphocytic leukemia: Development of a clinical tool and discovery of recurrent genomic alterations Proc Natl Acad Sci USA, 101, pp. 1039-1044.